Cutaneous melanoma, version 2.2019

Academic Article


  • © 2019 Harborside Press. All Rights Reserved. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cutaneous melanoma have been significantly revised over the past few years in response to emerging data on immune checkpoint inhibitor therapies and BRAF-targeted therapy. This article summarizes the data and rationale supporting extensive changes to the recommendations for systemic therapy as adjuvant treatment of resected disease and as treatment of unresectable or distant metastatic disease.
  • Digital Object Identifier (doi)

    Author List

  • Coit DG; Thompson JA; Albertini MR; Barker C; Carson WE; Contreras C; Daniels GA; DiMaio D; Fields RC; Fleming MD
  • Start Page

  • 367
  • End Page

  • 402
  • Volume

  • 17
  • Issue

  • 4